{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-336685","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2026-08-06T11:04:15+00:00","discovered_at":"2026-08-06T11:05:00.260856+00:00","generated_at":"2026-08-06T11:06:06.020408+00:00","sec_items":["1.01","2.02","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Korro Bio Q2 net loss $18.9M, cash $137.9M; exchanges 1M shares for pre-funded warrants","bullets":["Net loss $18.9M for Q2 2026 vs $25.8M in Q2 2025; no collaboration revenue due to Novo Nordisk pause.","Cash, equivalents and marketable securities $137.9M as of June 30, 2026; runway into H2 2028.","Exchange agreement: VenRock surrenders 1M shares for pre-funded warrants at $0.001 exercise price, no expiration.","KRRO-121 on track for first-in-human trial H2 2026; received EMA Orphan Drug Designation for UCDs.","Nominated KRRO-111 for AATD; preclinical data shows >90% editing and ~95% reduction of Z-AAT aggregates."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-336685","json":"https://secwatch.observer/filing/0001193125-26-336685.json","markdown":"https://secwatch.observer/filing/0001193125-26-336685.md","text":"https://secwatch.observer/filing/0001193125-26-336685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312526336685/0001193125-26-336685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312526336685/krro-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:06:06.020408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}